Pet Ct Scanning Services MarketSize, Share & Industry Analysis, 2026-2034By TypeBy ApplicationBy End UserBy ComponentBy Deployment Model

PET-CT scanning services combine positron emission tomography and X-ray computed tomography in a single hybrid imaging procedure, most commonly used to stage, monitor and assess treatment response in oncology, alongside cardiology and neurology applications. The category covers the scan procedure itself, delivered through fixed hospital-based imaging suites, standalone diagnostic imaging centers and mobile scanning units, along with the equipment maintenance and software services that support ongoing operation. Buyers are hospital radiology and nuclear medicine departments, independent diagnostic imaging chains, and outsourced imaging service operators that contract scanning capacity to health systems that do not operate their own hybrid scanners.

Growth of 7.98% a year carries the global pet ct scanning services market from USD 2.15 billion in 2025 to USD 4.25 billion in 2034. The full series behind that rate covers USD 1.55 billion in 2020, USD 2.1 billion in 2024, USD 2.3 billion in 2026 and USD 3.12 billion in 2030, with 2025 as the base year.

The type mix shifts over the period. Positron Emission Tomography (PET) Scanner is the largest line in 2025 at USD 1.355 billion, a 63.02% share, moving to USD 2.55 billion and 60% by 2034. X-ray Computed Tomography (CT) Scanner grows fastest at 8.91%, taking its share from 36.98% to 40%, while Positron Emission Tomography (PET) Scanner grows slowest at 7.4%. Share moves toward X-ray Computed Tomography (CT) Scanner and away from Positron Emission Tomography (PET) Scanner, though no line shrinks in revenue terms.

By application, Oncology accounts for 58% of 2025 revenue at USD 1.247 billion, reaching USD 2.338 billion and 55% by 2034. Neurology grows faster at 10.23% against 7.23%, moving from 14% of revenue to 17% by 2034. This axis divides the same revenue as the type split rather than adding to it, so the two are read together rather than summed.

Geographically, 42% of 2025 revenue sits in North America (USD 0.903 billion rising to USD 1.573 billion) ahead of Europe at 27% and USD 0.581 billion. Middle East and Africa is smallest, at 4%. Asia Pacific and Latin America gain share across the period, so growth is not distributed evenly between regions.

Coverage extends to five regions, two type lines and five segmentation axes over the full fifteen years. The 2025 total itself is arrived at by triangulating published aggregates against category proxies, not by an independent count, and the splits below are estimated on that same basis, a bound on their precision worth carrying into any use of them.

• Revenue grows from USD 2.15 billion in 2025 to USD 4.25 billion in 2034, a compound annual rate of 7.98%, having reached USD 2.1 billion in 2024 from USD 1.55 billion in 2020.
• 63.02% of 2025 revenue sits in Positron Emission Tomography (PET) Scanner (USD 1.355 billion) and it remains the largest type line in 2034 at USD 2.55 billion and 60%.
• At 8.91%, X-ray Computed Tomography (CT) Scanner grows faster than any other type line, moving from USD 0.795 billion and 36.98% of revenue in 2025 to USD 1.7 billion and 40% in 2034.
• The bull case puts 2034 revenue at USD 4.675 billion and the bear case at USD 3.825 billion, either side of the USD 4.25 billion base case, each with its own stated assumption in the full report.
• 42% of 2025 revenue is generated in North America, worth USD 0.903 billion and rising to USD 1.573 billion by 2034; Middle East and Africa is smallest at 4%.
• The United States accounts for 80% of North America in the base year, worth USD 0.722 billion in 2025 and reaching USD 1.258 billion by 2034, the worked country example carried through that region's chapters.
• Every line on all five segmentation axes and in each of the five regions carries its own revenue, share and growth rate for all fifteen years, 2020 through 2034, on a 2025 base.

The global pet ct scanning services market is shaped over 2026-2034 by three measurable movements: a change in the type mix, a shift in where revenue sits geographically, and the 7.98% rate carrying the total.

The direction of the market is not in question in any of the three. Each line and each region grows in revenue terms; the question is which takes the larger part of the growth.

The type mix tilts toward X-ray Computed Tomography (CT) Scanner. The widest spread on the type axis is between X-ray Computed Tomography (CT) Scanner at 8.91% and Positron Emission Tomography (PET) Scanner at 7.4%. X-ray Computed Tomography (CT) Scanner takes its share of revenue from 36.98% to 40% while Positron Emission Tomography (PET) Scanner gives up ground, from 63.02% to 60%. In absolute terms X-ray Computed Tomography (CT) Scanner rises from USD 0.795 billion to USD 1.7 billion, while Positron Emission Tomography (PET) Scanner rises from USD 1.355 billion to USD 2.55 billion. Both grow; the gap is wide enough to reshape the mix inside a single forecast window.

Asia Pacific and Latin America gain regional share. Asia Pacific moves from 22% of revenue in 2025 to 28% in 2034, worth USD 0.473 billion rising to USD 1.19 billion; Latin America moves from 5% of revenue in 2025 to 6% in 2034, worth USD 0.108 billion rising to USD 0.255 billion. Against that, North America at 42% moving to 37%, Europe at 27% moving to 25%, Middle East and Africa at 4% moving to 4%, a fall in share, not in revenue. The practical consequence is that regional weighting decides whether a participant matches the market rate or trails it, regardless of how its own revenue reads.

The series never breaks trajectory. Reading the series: USD 1.55 billion in 2020, USD 2.1 billion in 2024, USD 2.15 billion in 2025, USD 2.3 billion in 2026, USD 3.12 billion in 2030 and USD 4.25 billion in 2034. The forecast rate of 7.98% sits against 6.76% over the historical period, so the projection extends an observed trend instead of proposing a new one. That moves the planning question away from timing a turn and onto the type and regional mixes, where the actual movement is.

X-ray Computed Tomography (CT) Scanner carries the market's growth rate

Separate the 7.98% into its parts and three show up: an already-large base compounding, the type mix moving toward its faster lines, and regional growth landing unevenly.

Positron Emission Tomography (PET) Scanner grows below the market rate

What the bull case turns on

Revenue is concentrated in Positron Emission Tomography (PET) Scanner

North America holds 42% of the global pet ct scanning services market in 2025, worth USD 0.903 billion rising to USD 1.573 billion in 2034. It is a dominant region on this axis, first by revenue throughout the period.

By 2034 the share stands at 37%, a shift in share rather than in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Positron Emission Tomography (PET) Scanner leads here as it does globally, at 63.02% of 2025 revenue, and X-ray Computed Tomography (CT) Scanner again grows fastest at 8.91%. North America is reported axis by axis and country by country in the full study.

80% of North America's base-year revenue comes from the United States; USD 0.722 billion, rising to USD 1.258 billion by 2034. At 80% of regional revenue in the base year it is not one market among several, the region's trajectory is largely this country's trajectory. Regional revenue of USD 0.903 billion in 2025 and USD 1.573 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

The type pattern in the United States is the global one: 63.02% of 2025 revenue in Positron Emission Tomography (PET) Scanner, 60% by 2034, against 8.91% growth in X-ray Computed Tomography (CT) Scanner taking it from 36.98% to 40%. Because the country carries 80% of North America, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. Revenue by type for the United States is reported separately in the full report.

In the United States, veterinary CT scanning sits at the intersection of state-level veterinary practice law and federal radiation-safety oversight. The scanners themselves are treated by the Food and Drug Administration as radiation-emitting electronic products under its radiation control provisions, meaning manufacturers must meet applicable performance and safety standards regardless of whether the equipment is destined for human or animal use. Delivery of the scanning service, by contrast, falls to state veterinary medical boards, which license the practicing veterinarians and, in many states, the facility itself, while state radiation health agencies separately require registration of the equipment and adequate shielding, operator training, and safety protocols before a clinic may operate a scanner on patients.

Competition in the United States runs between the suppliers this study tracks: General Electric (GE HealthCare), Toshiba (Canon Medical Systems), Koninklijke Philips, Siemens Healthineers, Hitachi, Positron Corporation, Mediso, Yangzhou Kindsway Biotech, United Imaging Healthcare, Alliance HealthCare Services, Shared Imaging, Alliance Medical and RadNet. Positron Emission Tomography (PET) Scanner, at 63.02% of 2025 revenue, is where the volume sits, and X-ray Computed Tomography (CT) Scanner, growing at 8.91%, is where position changes hands over the forecast period. Per-company positioning and share at country level are in the full report only.

Within North America, Canada accounts for 20% of regional revenue and 8.42% of the global total, worth USD 0.181 billion in 2025 and USD 0.315 billion by 2034.

Europe holds 27% of the global pet ct scanning services market in 2025, worth USD 0.581 billion with USD 1.063 billion projected for 2034. It is a leading region on this axis, second by revenue throughout the period.

Its share moves to 25% by 2034, while nothing contracts here; other regions simply grow faster, which shows up as relative weight rather than as falling revenue.

Within the region the type split tracks the global one; 63.02% of 2025 revenue in Positron Emission Tomography (PET) Scanner, fastest growth of 8.91% in X-ray Computed Tomography (CT) Scanner. Revenue for Europe is broken out by every segmentation axis and by country in the full report.

30% of Europe's base-year revenue comes from Germany; USD 0.174 billion, rising to USD 0.319 billion by 2034. Its 30% of base-year regional revenue leads the region, though enough sits elsewhere that Europe is not a proxy for it. Regional revenue of USD 0.581 billion in 2025 and USD 1.063 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Demand in Germany follows the type mix reported at global level: Positron Emission Tomography (PET) Scanner is the largest line at 63.02% of 2025 revenue, moving to 60% by 2034, while X-ray Computed Tomography (CT) Scanner grows fastest at 8.91% and takes its share from 36.98% to 40%. Because the country carries 30% of Europe, a movement in its own mix shows up in the regional totals rather than being averaged away by neighbouring markets. The full report reports Germany by type separately.

In Germany, the delivery of pet CT scanning services is governed primarily by the federal veterinary professional framework, which restricts diagnostic imaging to licensed veterinarians operating under recognized practice standards, and by the national radiation protection regime, which treats CT as an ionizing-radiation modality requiring a specific licence to operate rather than simple equipment registration. Operators and staff must hold demonstrated expertise recognized under this radiation protection law before a facility may run a scanner on animals, and imaging equipment must be installed, shielded, and maintained to the technical standards set out under that same regime. General EU medical device rules for human diagnostic equipment do not extend to veterinary-only use of such scanners.

Competition in Germany runs between the suppliers this study tracks: General Electric (GE HealthCare), Toshiba (Canon Medical Systems), Koninklijke Philips, Siemens Healthineers, Hitachi, Positron Corporation, Mediso, Yangzhou Kindsway Biotech, United Imaging Healthcare, Alliance HealthCare Services, Shared Imaging, Alliance Medical and RadNet. The commercially relevant division is 63.02% of 2025 revenue in Positron Emission Tomography (PET) Scanner, where the volume is, against 8.91% growth in X-ray Computed Tomography (CT) Scanner, where share moves.

The United Kingdom is sized at USD 0.145 billion in 2025, rising to USD 0.266 billion by 2034; 6.74% of global revenue and 25% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

France is sized at USD 0.105 billion in 2025, rising to USD 0.191 billion by 2034; 4.88% of global revenue and 18% of Europe. It is reported separately from Germany across every segmentation axis in the full report.

In Asia Pacific, 22% of global revenue puts 2025 at USD 0.473 billion with USD 1.19 billion projected for 2034. By revenue it sits third across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share has moved up to 28%, at a pace above the 7.98% global rate, which is what makes this region worth reading separately rather than scaling from the total.

Positron Emission Tomography (PET) Scanner leads here as it does globally, at 63.02% of 2025 revenue, and X-ray Computed Tomography (CT) Scanner again grows fastest at 8.91%. Per-axis and per-country detail for Asia Pacific sits in the full report.

The largest single market in Asia Pacific is Japan, at USD 0.166 billion in 2025 and USD 0.333 billion in 2034. At 35% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. Set against USD 0.473 billion and USD 1.19 billion for the region, it is why this market rather than a smaller one is the one reported in full.

Demand in Japan follows the type mix reported at global level: Positron Emission Tomography (PET) Scanner is the largest line at 63.02% of 2025 revenue, moving to 60% by 2034, while X-ray Computed Tomography (CT) Scanner grows fastest at 8.91% and takes its share from 36.98% to 40%. With 35% of Asia Pacific concentrated here, a change in this country's mix is visible in the regional figures instead of being diluted by its neighbours. Revenue by type for Japan is reported separately in the full report.

In Japan, veterinary CT scanning services are shaped by the Veterinarians Act, which limits the practice of animal diagnostic imaging to licensed veterinarians and veterinary facilities registered with the relevant prefectural authority, under the oversight of the Ministry of Agriculture, Forestry and Fisheries. Because CT equipment emits ionizing radiation, its installation and use in a veterinary setting also falls under national laws addressing radiation hazard prevention, which impose facility shielding requirements, equipment inspection, and operator safety training distinct from the human-medical radiological framework. Suppliers of imaging equipment to veterinary clinics must ensure the hardware meets applicable electrical and radiation-safety product standards before it can be installed and operated commercially.

Competition in Japan runs between the suppliers this study tracks: General Electric (GE HealthCare), Toshiba (Canon Medical Systems), Koninklijke Philips, Siemens Healthineers, Hitachi, Positron Corporation, Mediso, Yangzhou Kindsway Biotech, United Imaging Healthcare, Alliance HealthCare Services, Shared Imaging, Alliance Medical and RadNet. Two different problems sit on the same axis: holding Positron Emission Tomography (PET) Scanner at 63.02% of 2025 revenue, and taking X-ray Computed Tomography (CT) Scanner while it grows at 8.91%.

China is sized at USD 0.142 billion in 2025, rising to USD 0.417 billion by 2034; 6.6% of global revenue and 30% of Asia Pacific. It is reported separately from Japan across every segmentation axis in the full report.

Within Asia Pacific, India accounts for 15% of regional revenue and 3.3% of the global total, worth USD 0.071 billion in 2025 and USD 0.214 billion by 2034.

5% of the global pet ct scanning services market sits in Latin America in 2025, worth USD 0.108 billion with USD 0.255 billion projected for 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

By 2034 the share has moved up to 6%, because it outgrows the market's 7.98%; the revenue added here is disproportionate to where the region started.

Segment composition follows the global pattern: Positron Emission Tomography (PET) Scanner largest at 63.02% of 2025 revenue, X-ray Computed Tomography (CT) Scanner fastest at 8.91%. The full report breaks Latin America out along every axis and by country.

54.6% of Latin America's base-year revenue comes from Brazil; USD 0.059 billion, rising to USD 0.14 billion by 2034. At 54.6% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. Set against USD 0.108 billion and USD 0.255 billion for the region, it is why this market rather than a smaller one is the one reported in full.

Brazil buys along the same lines as the market globally; Positron Emission Tomography (PET) Scanner first at 63.02% of 2025 revenue and 60% in 2034, X-ray Computed Tomography (CT) Scanner fastest at 8.91% on a share moving from 36.98% to 40%. Since 54.6% of Latin America's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. Brazil carries its own type breakdown in the full report.

In Brazil, the practice of veterinary medicine, including diagnostic imaging such as CT scanning of companion animals, is overseen by the Federal Council of Veterinary Medicine together with the regional veterinary councils, which license practitioners and accredit the clinics offering such services. Because CT equipment is a source of ionizing radiation, its installation and operation are additionally subject to national nuclear-safety oversight, which requires facility licensing, shielding assessment, and periodic inspection of the equipment separate from veterinary licensure itself. Suppliers placing imaging equipment into the Brazilian market must also satisfy applicable national health-surveillance requirements governing electromedical equipment safety and quality before commercial installation.

In Brazil the field is General Electric (GE HealthCare), Toshiba (Canon Medical Systems), Koninklijke Philips, Siemens Healthineers, Hitachi, Positron Corporation, Mediso, Yangzhou Kindsway Biotech, United Imaging Healthcare, Alliance HealthCare Services, Shared Imaging, Alliance Medical and RadNet. Two different problems sit on the same axis: holding Positron Emission Tomography (PET) Scanner at 63.02% of 2025 revenue, and taking X-ray Computed Tomography (CT) Scanner while it grows at 8.91%.

Mexico is sized at USD 0.032 billion in 2025, rising to USD 0.077 billion by 2034; 1.49% of global revenue and 29.6% of Latin America. It is reported separately from Brazil across every segmentation axis in the full report.

Middle East and Africa holds 4% of the global pet ct scanning services market in 2025, worth USD 0.086 billion rising to USD 0.17 billion in 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

4% of global revenue sits here in 2034, below the 2025 level, and the region keeps growing in absolute terms while others expand faster, a change in relative weight, not a decline in demand.

The type mix reported at global level applies here, with Positron Emission Tomography (PET) Scanner the largest line at 63.02% of 2025 revenue and X-ray Computed Tomography (CT) Scanner the fastest-growing at 8.91%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 0.039 billion in 2025 and USD 0.077 billion in 2034. It accounts for 45.3% of regional revenue in the base year, the largest single share without dominating the region outright. Regional revenue of USD 0.086 billion in 2025 and USD 0.17 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

The type pattern in Saudi Arabia is the global one: 63.02% of 2025 revenue in Positron Emission Tomography (PET) Scanner, 60% by 2034, against 8.91% growth in X-ray Computed Tomography (CT) Scanner taking it from 36.98% to 40%. Since 45.3% of Middle East and Africa's revenue is generated here, the regional numbers inherit this market's mix rather than smoothing it out. The full report reports Saudi Arabia by type separately.

In Saudi Arabia, medical imaging equipment, including CT scanners intended for veterinary use, falls under the registration and market-authorization authority of the Saudi Food and Drug Authority, which requires suppliers to register the device and demonstrate conformity with recognized international safety and quality standards before it may be imported or placed into service. The practice of veterinary medicine and the licensing of veterinary clinics and practitioners is separately overseen by the ministry responsible for agriculture and animal resources, which sets facility and staffing requirements for diagnostic services offered to animal patients. Radiation-emitting equipment such as CT scanners is additionally subject to national nuclear and radiological safety oversight governing installation, shielding, and operator qualification.

General Electric (GE HealthCare), Toshiba (Canon Medical Systems), Koninklijke Philips, Siemens Healthineers, Hitachi, Positron Corporation, Mediso, Yangzhou Kindsway Biotech, United Imaging Healthcare, Alliance HealthCare Services, Shared Imaging, Alliance Medical and RadNet are the suppliers covered in Saudi Arabia. The commercially relevant division is 63.02% of 2025 revenue in Positron Emission Tomography (PET) Scanner, where the volume is, against 8.91% growth in X-ray Computed Tomography (CT) Scanner, where share moves.

1.21% of global revenue is generated in the United Arab Emirates; USD 0.026 billion in 2025, reaching USD 0.051 billion in 2034, and 30.2% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by Type, Application, End User, Component, Deployment Model, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.